Original research
by
Rigg, Khary K.
Release Date
2024
Geography
USA
Language of Resource
English
Full Text Available
No
Open Access / OK to Reproduce
No
Peer Reviewed
Yes
Objective
The objective of this study, therefore, was to identify/explain the most salient attitudes toward extended-release naltrexone (XR-NTX; Vivitrol®) as a form of OUD treatment among African Americans.
Findings/Key points
Study findings suggest that African Americans who use opioids may have more favorable attitudes toward XR-NTX than other medications for OUD (e.g., methadone), which tend to be highly stigmatized.
Design/methods
In-depth interviews (n = 30)
Keywords
Equity
Substitution/OAT
About PWUD
